Microscopy Core, New Directors, Commercialization among Priorities for Max Planck Florida | GenomeWeb

By Alex Philippidis

NEW YORK (GenomeWeb News) — Max Planck Florida Institute will spend the next several months growing its core of microscopy equipment, hiring three scientific directors — one of which will double as CEO — and building relations with neighboring research and academic institutions along with the permanent facility it has begun constructing in Jupiter, Fla., the institute's new chief scientific facilities officer told GenomeWeb Daily News.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.